Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | PDE6D | O43924 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24639599 | 0.88 | L3MBTL1 (0.33) | L3MBTL1KDM4EATMPTGS1PTGS2 | |
| SCHEMBL24639182 | 0.87 | L3MBTL1 (0.45) | L3MBTL1KDM4EATMPOLBBACE1 | |
| SCHEMBL24639193 | 0.86 | KDM4E (0.41) | L3MBTL1KDM4EATMBACE1 | |
| SCHEMBL24639009 | 0.86 | KDM4E (0.44) | L3MBTL1KDM4EATMPOLBBACE1 | |
| SCHEMBL24638947 | 0.82 | KDM4E (0.40) | L3MBTL1KDM4EATMPOLB | |
| SCHEMBL24638943 | 0.82 | KDM4E (0.40) | L3MBTL1KDM4EATMPOLB | |
| SCHEMBL24638946 | 0.82 | KDM4E (0.40) | L3MBTL1KDM4EATMPOLB | |
| SCHEMBL24639735 | 0.82 | KDM4E (0.36) | L3MBTL1KDM4EATMPTGS1PTGS2 | |
| SCHEMBL19106717 | 0.80 | KDM4E (0.46) | L3MBTL1KDM4EATMPOLBBACE1 | |
| SCHEMBL17705485 | 0.80 | CNR1 (0.40) | L3MBTL1KDM4EPTGS1PTGS2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220310934-A1 | COMPOUND INCLUDING NITROGEN EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220310934-A1 | COMPOUND INCLUDING NITROGEN EMITTING DEVICE INCLUDING THE SAME | NOS1, NOX1, NPM1 | L3MBTL1 1046/4885KDM4E 1775/4885ATM 3242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.